Latest news from Abeona Therapeutics on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/abeona-therapeutics-enrolls-first-patient-in-phase-1-2-trial-with-abo-102-gene-therapy-for-patients-with-sanfilippo-syndrome-type-a-mps-iiia/?sc=rsin /articles/abeona-therapeutics-enrolls-first-patient-in-phase-1-2-trial-with-abo-102-gene-therapy-for-patients-with-sanfilippo-syndrome-type-a-mps-iiia/?sc=rsin Tue, 17 May 2016 07:30:00 EST First-In-Man Gene Therapy Delivering AAV by Single Intravenous Injection to treat Central Nervous System and Peripheral Manifestations of Disease Abeona Therapeutics /articles/with-new-spotlight-on-batten-disease-can-gene-therapy-provide-an-answer/?sc=rsin /articles/with-new-spotlight-on-batten-disease-can-gene-therapy-provide-an-answer/?sc=rsin Wed, 01 Jul 2015 14:05:00 EST According to Dr. Tammy Kielian, there are no treatments available that can halt or reverse the symptoms of children with juvenile Batten disease, but earlier studies using AAV gene therapy at UNMC have demonstrated significant and promising results in animal models of the disease. Abeona Therapeutics